Exploring the Superiority of Kidney Transplantation Over Dialysis in Renal Replacement Therapy

January 12, 2024

Exploring the Superiority of Kidney Transplantation Over Dialysis in Renal Replacement Therapy

January 12, 2024

Kidney transplantation represents a significant advancement in the management of end-stage kidney disease (ESKD), transcending beyond being merely an alternative treatment option to being a transformative approach that substantially enhances patient outcomes. This review will focus on elucidating the reasons why kidney transplantation is frequently regarded as a superior therapeutic strategy compared to long-term dialysis.

A Comparative Lens: Transplantation vs. Dialysis

The debate of kidney transplantation versus dialysis is intricate, but science leans favorably towards transplantation. A pivotal study by Wolfe et al., published in the New England Journal of Medicine in 1999, sheds light on this. The study found that post-transplantation, patients’ risk of death dropped by 68% compared to those waiting on dialysis [The NEJM, 1999]. This is a staggering statistic, considering the United States Renal Data System (USRDS) reports a five-year survival rate exceeding 85% for transplant recipients, a stark contrast to the 35-40% survival rate for those on dialysis.

A systematic review and meta-analysis published in The BMJ investigated the survival benefit of transplantation versus dialysis for waitlisted kidney failure patients. The study, which included data up to March 1, 2021, analyzed 48 observational studies involving 1,245,850 patients. It found that 92% of these studies reported a long-term survival benefit associated with transplantation compared with dialysis. In 18 studies suitable for meta-analysis, kidney transplantation showed a significant survival benefit (hazard ratio 0.45, 95% confidence interval 0.39 to 0.54; P<0.001) [The BMJ, 2021].

A 2022 study published in JAMA Network Open evaluated the survival benefit of first single-organ deceased donor kidney transplantation compared with long-term dialysis across various ages in transplant-eligible patients with kidney failure. This cohort study, which included 4,445 adults, found that kidney transplantation prolonged life expectancy across all patient ages compared with continuing dialysis [JAMA Network Open, 2022].

The Quality-of-Life Argument

It’s not just about living longer; it’s about living better.  The impact of kidney transplantation on quality of life is profound, including improvements in energy levels, cognitive function, and overall well-being.  Kidney transplantation frees patients from the rigorous schedule of dialysis, offering more freedom and flexibility in their daily lives.

There are several peer-reviewed clinical studies that have investigated the physical and mental health outcomes in kidney transplant recipients compared to dialysis patients. One such study conducted in Palestine compared the health-related quality of life (HRQOL) between kidney transplant recipients (KTRs) and hemodialysis (HD) patients. This study found that KTRs had significantly higher HRQOL scores than HD patients across all domains and subscales of the SF-36, a widely used health survey instrument. These domains include physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health. The study adjusted for various sociodemographic variables and still found that KTRs exhibited better HRQOL compared to HD patients, indicating a significant improvement in both physical and mental health aspects following a kidney transplant [BMC Nephrology, 2021].

One comprehensive systematic review analyzed life participation activities among adults treated with hemodialysis, peritoneal dialysis, and kidney transplantation. The review included 46 studies conducted over a period from 1985 to 2011 in various locations, including the United States. Most of these studies reported greater life participation rates for patients with kidney transplants compared to those receiving either hemodialysis or peritoneal dialysis. This suggests that kidney transplant recipients may experience better rates of life participation, which encompasses aspects such as physical function, travel, recreation, freedom, and work-related activities. The results were consistent across different patient populations and remained true even after adjusting for potential confounding factors [AJKD, 2013].

Transplant patients often talk about how their lives are transformed post-surgery. They speak of fewer dietary restrictions, a return to normalcy, and an overall uplift in their daily experiences. This isn’t anecdotal evidence alone.  Improved quality of life for transplant recipients can lead to better overall health outcomes, which indirectly reduces healthcare burden. Patients who feel better physically and mentally are less likely to require additional healthcare services. Furthermore, the ability to return to work and participate more fully in society reduces the indirect costs associated with loss of productivity, which is a notable issue for many dialysis patients.

Reduced Healthcare Burden

Kidney transplantation also reduces the overall healthcare burden compared to dialysis. 

Frequency of Treatment: Dialysis patients typically require treatments multiple times per week, which can be time-consuming and physically taxing. In contrast, once a kidney transplant patient has recovered from the surgery, they no longer require such frequent treatments. This reduction in treatment frequency directly translates to less strain on healthcare resources.

Hospitalizations and Complications: Patients on dialysis are at a higher risk for hospitalizations due to complications related to their treatment, such as infections or cardiovascular issues. Kidney transplant recipients, particularly after the initial post-operative period, tend to have fewer hospitalizations and complications. This difference leads to a reduction in healthcare utilization.

Use of Healthcare Facilities: Dialysis requires specialized equipment and facilities, which can be a significant resource burden for healthcare providers. Transplantation, on the other hand, moves the primary care of the patient away from these resource-intensive settings, freeing up these resources for other patients and purposes.

Medication and Follow-up: Although kidney transplant recipients require lifelong medication and follow-up, the intensity and frequency of this care are generally less burdensome than the ongoing requirements of dialysis. This aspect contributes to a more efficient use of healthcare resources.

Kidney transplantation can significantly reduce the healthcare burden compared to dialysis, considering the aspects of treatment frequency, hospitalizations, long-term costs, indirect societal costs, resource allocation, and ongoing care requirements. These factors play a crucial role in healthcare planning and decision-making, both at the individual patient level and in broader health policy contexts.

Economically Speaking

Finally, the financial aspect of kidney transplantation versus dialysis is an important consideration. While the upfront cost of a transplant might seem daunting, it’s an investment that pays off in the long run. The initial cost of a kidney transplant is high but is comparative to the cost of a patient who ‘crashes’ into dialysis without options counseling.  Over time, kidney transplantation becomes more cost-effective compared to dialysis.

This cost-effectiveness benefits not only patients but also the healthcare system in terms of reduced long-term expenses.

Concluding Thoughts

In summary, kidney transplantation offers significant benefits over dialysis. It leads to improved survival rates, enhanced physical and mental health, significant per patient per year cost savings, and a reduced burden on healthcare resources.  Kidney transplantation can significantly improve the quality of life for patients and their families, providing them with greater freedom and the ability to engage more fully in various life activities compared to those on dialysis. This improvement is a crucial consideration for patients with end-stage renal disease when evaluating their treatment options.  While kidney transplantation is not devoid of challenges, its benefits are undeniable, offering a brighter, more hopeful future for many grappling with ESRD.  It’s crucial for this conversation to continue, for patients and healthcare providers to weigh all options, keeping the patient’s overall health and preferences at the heart of the renal replacement therapy decision-making process.

References

Hilbrands, L. B., Duivenvoorden, R., Vart, P., et al. (2022). Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months After a Diagnosis of COVID-19. Transplantation, 106(5), 1023-1033.

Howard, K., Salkeld, G., White, S., McDonald, S., Chadban, S., Craig, J. C., & Cass, A. (2005). The Cost-Effectiveness of Increasing Kidney Transplantation and Home-Based Dialysis. Nephrology Dialysis Transplantation, 20(2), 295-300.

Jumaa, M. I., Damiri, B. R., Koni, A. A., Mo’athen, A. A. S., & Qasrawi, R. H. (2021). Quality of Life for Kidney Transplant Recipients and Hemodialysis Patients in Palestine: A Cross-Sectional Study. BMC Nephrology, 22, 167. doi:10.1186/s12882-021-02364-0.

Laupacis, A., Keown, P., Pus, N., Krueger, H., Ferguson, B., Wong, C., & Muirhead, N. (2019). A Study of the Quality of Life and Cost-Utility of Renal Transplantation. Kidney International, 50(1), 235-242. doi:10.1038/ki.1996.307.

Massie, A. B., Holscher, C. M., Henderson, M. L., Fahmy, L. M., Thomas, A. G., Al Ammary, F., … & Segev, D. L. (2022). Survival Benefit of First Single-Organ Deceased Donor Kidney Transplantation Compared With Long-term Dialysis Across Ages in Transplant-Eligible Patients With Kidney Failure. JAMA Network Open, 5(6), e2114056.

Matas, A. J., et al. (2000). Long-term follow-up of living kidney donors: quality of life after donation. JAMA.

Park, S. K., Choi, S. W., Kim, M. K., Kim, S. S., Kim, S., & Han, D. J. (2021). Better Health-Related Quality of Life in Kidney Transplant Patients Compared to Chronic Kidney Disease Patients with Similar Renal Function. PLOS ONE, 16(6), e0252625.

Rao, P. S., Schaubel, D. E., Jia, X., Li, S., Port, F. K., & Saran, R. (2007). Survival on Dialysis Post-Kidney Transplant Failure: Results from the Scientific Registry of Transplant Recipients. American Journal of Kidney Diseases, 49(2), 294-300. 

Tonelli, M., Wiebe, N., Knoll, G., Bello, A., Browne, S., Jadhav, D., … & Klarenbach, S. (2021). Survival for Waitlisted Kidney Failure Patients Receiving Transplantation Versus Remaining on Waiting List: Systematic Review and Meta-Analysis. The BMJ, 372, n115.

Tong, A., Sainsbury, P., & Craig, J. C. (2013). Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. American Journal of Kidney Diseases, 62(5), 953-973.

Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L. Y. C., Held, P. J., & Port, F. K. (2020). Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant. The New England Journal of Medicine, 341(23), 1725-1730. 

United States Renal Data System. (2021). USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.

Get in Touch

Whether you have questions, feedback, or just want to say hello, we’re here to listen and assist you every step of the way.

Headquarters Location

Sarasota, FL

Email

info@hopewellhealth.com

Other Blogs: